THE ROLE OF TRANSESOPHAGEAL OVERDRIVE PACING IN TERMINATING PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Trương Quốc Cường 1 , , Trương Quang Khanh 1 , Nguyễn Thị Hồng Nhung 1 , Ngô Nguyễn Quan Huy 1 , Huỳnh Duy Mẫn 1
1 Thong Nhat Hospital image/svg+xml
* Corresponding author:

Article Information

Metrics
Downloads: 25 Views: 62
Published
2025-10-10
Section
Case Report
Categories

Download Article

How to Cite

1.
Quốc Cường T, Quang Khanh T, Thị Hồng Nhung N, Nguyễn Quan Huy N, Duy Mẫn H. THE ROLE OF TRANSESOPHAGEAL OVERDRIVE PACING IN TERMINATING PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA. JHA [Internet]. Vietnam; 2025 Oct. 10 [cited 2025 Dec. 8];1(4):135–142. https://tcsuckhoelaohoa.vn/bvtn/article/view/123 doi: 10.63947/bvtn.v1i4.22
Loading...
Loading citation...

Abstract

Transesophageal overdrive pacing is an accepted method for the diagnosis and treatment of paroxysmal supraventricular tachycardias, although is not used frequently in clinical practice. We describe four complex cases of paroxysmal supraventricular arrhythmia to review the role of transesophageal overdrive pacing in the interruption of paroxysmal supraventricular tachycardia. In these cases depend on clinical features such as pregnancy, resistance to antiarrhythmic drugs, and comorbid bradycardia that make it difficult to treat. These cases were successfully converted by transesophageal overdrive atrial pacing. Transesophageal overdrive atrial pacing is a low-cost, simple and safe procedure that can be performed at the bedside and can do many times, especially in patients, whose condition makes difficult the usage of medicines.

Keywords

Transesophageal overdrive Pacing Paroxysmal Supraventricular Tachycardia Tachycardia Termination

References

  1. Katritsis, D.G., et al., European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). Eur Heart J, 2018. 39(16): p. 1442-1445.
  2. Orejarena, L.A., et al., Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol, 1998. 31(1): p. 150-7. DOI: https://doi.org/10.1016/S0735-1097(97)00422-1
  3. Regitz-Zagrosek, V., et al., ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J, 2011. 32(24): p. 3147-97. DOI: https://doi.org/10.1093/eurheartj/ehr218
  4. Silversides, C.K., et al., Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol, 2006. 97(8): p. 1206-12. DOI: https://doi.org/10.1016/j.amjcard.2005.11.041
  5. Roberts, A., et al., Management of palpitations and cardiac arrhythmias in pregnancy. The Obstetrician & Gynaecologist, 2019. 21(4): p. 263-270. DOI: https://doi.org/10.1111/tog.12599
  6. Saoudi, N., et al., Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol, 2001. 12(7): p. 852-66. DOI: https://doi.org/10.1046/j.1540-8167.2001.00852.x
  7. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med, 1987. 316(23): p. 1429-35. DOI: https://doi.org/10.1056/NEJM198706043162301
  8. Lip, G.Y.H., et al., European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EP Europace, 2015. 18(1): p. 12-36. DOI: https://doi.org/10.1093/europace/euv191
  9. Brugada, J., et al., 2019 ESC guidelines for the management of patients with supraventricular tachycardia the task force for the management of patients with supraventricular tachycardia of the European society of Cardiology (ESC) developed in collaboration with the association for European paediatric and congenital Cardiology (AEPC). European heart journal, 2020. 41(5): p. 655-720. DOI: https://doi.org/10.1093/eurheartj/ehz467
  10. Appelboam, A., et al., Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet, 2015. 386(10005): p. 1747-53. DOI: https://doi.org/10.1016/S0140-6736(15)61485-4
  11. Rankin, A., et al., Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Heart, 1989. 62(3): p. 195-203. DOI: https://doi.org/10.1136/hrt.62.3.195
  12. Glatter, K.A., et al., Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation, 1999. 99(8): p. 1034-1040. DOI: https://doi.org/10.1161/01.CIR.99.8.1034
  13. Hood, M.A. and W.M. Smith, Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. Am Heart J, 1992. 123(6): p. 1543-9. DOI: https://doi.org/10.1016/0002-8703(92)90807-8
  14. Marco, C.A. and J.F. Cardinale, Adenosine for the treatment of supraventricular tachycardia in the ED. Am J Emerg Med, 1994. 12(4): p. 485-8. DOI: https://doi.org/10.1016/0735-6757(94)90069-8
  15. Link, M.S., et al., Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 2010. 122(18 Suppl 3): p. S706-19. DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.970954
  16. Page, R.L., et al., 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation, 2016. 133(14): p. e471-505.
  17. Wilkins, L.W., Part 7.3: Management of Symptomatic Bradycardia and Tachycardia. Circulation, 2005. 112. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.166558
  18. Keller, K.B. and L. Lemberg, The sick sinus syndrome. American Journal of Critical Care, 2006. 15(2): p. 226-229. DOI: https://doi.org/10.4037/ajcc2006.15.2.226
  19. Hessling, G., K. Brockmeier, and H.E. Ulmer, Transesophageal electrocardiography and atrial pacing in children. Journal of Electrocardiology, 2002. 35(4, Part B): p. 143-149. DOI: https://doi.org/10.1054/jelc.2002.37172
  20. Verbeet, T., J. Castro, and P. Decoodt, Transesophageal pacing: a versatile diagnostic and therapeutic tool. Indian Pacing Electrophysiol J, 2003. 3(4): p. 202-9.
  21. Santini, M., et al., Transesophageal pacing. Pacing Clin Electrophysiol, 1990. 13(10): p. 1298-323. DOI: https://doi.org/10.1111/j.1540-8159.1990.tb02029.x
  22. Favale, S., et al., Ventricular fibrillation induced by transesophageal atrial pacing in hypertrophic cardiomyopathy. Eur Heart J, 1987. 8(8): p. 912-6. DOI: https://doi.org/10.1093/oxfordjournals.eurheartj.a062358
  23. Bass, J. and C. Gorbatkin, Transesophageal Cardiac Pacing, in Reichman's Emergency Medicine Procedures, 3e, E.F. Reichman, Editor. 2018, McGraw-Hill Education: New York, NY.
  24. Barnes, E.J., F. Eben, and D. Patterson, Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. Bjog, 2002. 109(12): p. 1406-7. DOI: https://doi.org/10.1046/j.1471-0528.2002.02113.x

License

© 2025 The Author(s). Published by Journal of Health and Aging.